世界のβ-ラクタム＆β-ラクタマーゼ阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Beta-lactam and Beta-lactamase Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5614 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、β-ラクタム＆β-ラクタマーゼ阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペニシリン、セファロスポリン、カルバペネム、モノバクタム、組み合わせ）、用途別市場規模（経口、静脈内、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・β-ラクタム＆β-ラクタマーゼ阻害剤の市場動向 ・企業の競争状況、市場シェア ・β-ラクタム＆β-ラクタマーゼ阻害剤の種類別市場規模と予測2016-2027（ペニシリン、セファロスポリン、カルバペネム、モノバクタム、組み合わせ） ・β-ラクタム＆β-ラクタマーゼ阻害剤の用途別市場規模と予測2016-2027（経口、静脈内、その他） ・β-ラクタム＆β-ラクタマーゼ阻害剤の北米市場規模2016-2027（アメリカ、カナダ） ・β-ラクタム＆β-ラクタマーゼ阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・β-ラクタム＆β-ラクタマーゼ阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・β-ラクタム＆β-ラクタマーゼ阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・β-ラクタム＆β-ラクタマーゼ阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Allergan Plc.、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline plc、Merck & Co. Inc.、Mylan N.V.、Novartis International AG (Sandoz)、Pfizer Inc.、Sanofi、Teva Pharmaceutical Industries Ltd） ・結論

Beta-lactam antibiotics are a class of antibiotics consisting of all antibiotic agents that contain a beta-lactam ring in their molecular structures. This includes penicillin derivatives, cephalosporins, monobactams, and carbapenems.
These are the antimicrobial substances or compounds that fight against bacterial infections and sometimes with protozoan infections. In addition, these medications either kill the bacteria directly or stop the bacteria from growing. However, these drugs are easily available at over-the-counter (OTC) and one can buy these without a prescription in most of the countries, which leads to overuse or misuse. Thereby, bacterial resistance is developing the beta-lactam antibiotics.

Market Analysis and Insights: Global Beta-lactam and Beta-lactamase Inhibitors Market
The global Beta-lactam and Beta-lactamase Inhibitors market size is projected to reach US$ 25660 million by 2027, from US$ 22740 million in 2020, at a CAGR of 1.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Beta-lactam and Beta-lactamase Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Beta-lactam and Beta-lactamase Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Beta-lactam and Beta-lactamase Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Beta-lactam and Beta-lactamase Inhibitors market.

Global Beta-lactam and Beta-lactamase Inhibitors Scope and Market Size
Beta-lactam and Beta-lactamase Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Beta-lactam and Beta-lactamase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Penicillin
Cephalosporin
Carbapenem
Monobactam
Combination

Segment by Application
Oral
Intravenous
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Allergan Plc.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
Merck & Co. Inc.
Mylan N.V.
Novartis International AG (Sandoz)
Pfizer Inc.
Sanofi
Teva Pharmaceutical Industries Ltd

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Penicillin
1.2.3 Cephalosporin
1.2.4 Carbapenem
1.2.5 Monobactam
1.2.6 Combination
1.3 Market by Application
1.3.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oral
1.3.3 Intravenous
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Perspective (2016-2027)
2.2 Beta-lactam and Beta-lactamase Inhibitors Growth Trends by Regions
2.2.1 Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Beta-lactam and Beta-lactamase Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Beta-lactam and Beta-lactamase Inhibitors Industry Dynamic
2.3.1 Beta-lactam and Beta-lactamase Inhibitors Market Trends
2.3.2 Beta-lactam and Beta-lactamase Inhibitors Market Drivers
2.3.3 Beta-lactam and Beta-lactamase Inhibitors Market Challenges
2.3.4 Beta-lactam and Beta-lactamase Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Revenue
3.1.1 Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Beta-lactam and Beta-lactamase Inhibitors Revenue
3.4 Global Beta-lactam and Beta-lactamase Inhibitors Market Concentration Ratio
3.4.1 Global Beta-lactam and Beta-lactamase Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Beta-lactam and Beta-lactamase Inhibitors Revenue in 2020
3.5 Beta-lactam and Beta-lactamase Inhibitors Key Players Head office and Area Served
3.6 Key Players Beta-lactam and Beta-lactamase Inhibitors Product Solution and Service
3.7 Date of Enter into Beta-lactam and Beta-lactamase Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Beta-lactam and Beta-lactamase Inhibitors Breakdown Data by Type
4.1 Global Beta-lactam and Beta-lactamase Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Type (2022-2027)

5 Beta-lactam and Beta-lactamase Inhibitors Breakdown Data by Application
5.1 Global Beta-lactam and Beta-lactamase Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size (2016-2027)
6.2 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
6.2.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2027)
6.3 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application
6.3.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2027)
6.4 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
6.4.1 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size (2016-2027)
7.2 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
7.2.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2027)
7.3 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application
7.3.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2027)
7.4 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
7.4.1 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
8.2.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application
8.3.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region
8.4.1 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size (2016-2027)
9.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
9.2.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application
9.3.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
9.4.1 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type
10.2.1 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application
10.3.1 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country
10.4.1 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Introduction
11.1.4 Abbott Laboratories Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Allergan Plc.
11.2.1 Allergan Plc. Company Details
11.2.2 Allergan Plc. Business Overview
11.2.3 Allergan Plc. Beta-lactam and Beta-lactamase Inhibitors Introduction
11.2.4 Allergan Plc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
11.2.5 Allergan Plc. Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Beta-lactam and Beta-lactamase Inhibitors Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Introduction
11.4.4 GlaxoSmithKline plc Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Merck & Co. Inc.
11.5.1 Merck & Co. Inc. Company Details
11.5.2 Merck & Co. Inc. Business Overview
11.5.3 Merck & Co. Inc. Beta-lactam and Beta-lactamase Inhibitors Introduction
11.5.4 Merck & Co. Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
11.5.5 Merck & Co. Inc. Recent Development
11.6 Mylan N.V.
11.6.1 Mylan N.V. Company Details
11.6.2 Mylan N.V. Business Overview
11.6.3 Mylan N.V. Beta-lactam and Beta-lactamase Inhibitors Introduction
11.6.4 Mylan N.V. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
11.6.5 Mylan N.V. Recent Development
11.7 Novartis International AG (Sandoz)
11.7.1 Novartis International AG (Sandoz) Company Details
11.7.2 Novartis International AG (Sandoz) Business Overview
11.7.3 Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Introduction
11.7.4 Novartis International AG (Sandoz) Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
11.7.5 Novartis International AG (Sandoz) Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Beta-lactam and Beta-lactamase Inhibitors Introduction
11.8.4 Pfizer Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
11.8.5 Pfizer Inc. Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Beta-lactam and Beta-lactamase Inhibitors Introduction
11.9.4 Sanofi Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Teva Pharmaceutical Industries Ltd
11.10.1 Teva Pharmaceutical Industries Ltd Company Details
11.10.2 Teva Pharmaceutical Industries Ltd Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Introduction
11.10.4 Teva Pharmaceutical Industries Ltd Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
11.10.5 Teva Pharmaceutical Industries Ltd Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Penicillin
Table 3. Key Players of Cephalosporin
Table 4. Key Players of Carbapenem
Table 5. Key Players of Monobactam
Table 6. Key Players of Combination
Table 7. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions (2016-2021)
Table 11. Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions (2022-2027)
Table 13. Beta-lactam and Beta-lactamase Inhibitors Market Trends
Table 14. Beta-lactam and Beta-lactamase Inhibitors Market Drivers
Table 15. Beta-lactam and Beta-lactamase Inhibitors Market Challenges
Table 16. Beta-lactam and Beta-lactamase Inhibitors Market Restraints
Table 17. Global Beta-lactam and Beta-lactamase Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Players (2016-2021)
Table 19. Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Beta-lactam and Beta-lactamase Inhibitors as of 2020)
Table 20. Ranking of Global Top Beta-lactam and Beta-lactamase Inhibitors Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Beta-lactam and Beta-lactamase Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Beta-lactam and Beta-lactamase Inhibitors Product Solution and Service
Table 24. Date of Enter into Beta-lactam and Beta-lactamase Inhibitors Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2016-2021)
Table 28. Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Beta-lactam and Beta-lactamase Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Application (2016-2021)
Table 32. Global Beta-lactam and Beta-lactamase Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Beta-lactam and Beta-lactamase Inhibitors Product
Table 67. Abbott Laboratories Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Allergan Plc. Company Details
Table 70. Allergan Plc. Business Overview
Table 71. Allergan Plc. Beta-lactam and Beta-lactamase Inhibitors Product
Table 72. Allergan Plc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
Table 73. Allergan Plc. Recent Development
Table 74. F. Hoffmann-La Roche Ltd. Company Details
Table 75. F. Hoffmann-La Roche Ltd. Business Overview
Table 76. F. Hoffmann-La Roche Ltd. Beta-lactam and Beta-lactamase Inhibitors Product
Table 77. F. Hoffmann-La Roche Ltd. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
Table 78. F. Hoffmann-La Roche Ltd. Recent Development
Table 79. GlaxoSmithKline plc Company Details
Table 80. GlaxoSmithKline plc Business Overview
Table 81. GlaxoSmithKline plc Beta-lactam and Beta-lactamase Inhibitors Product
Table 82. GlaxoSmithKline plc Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
Table 83. GlaxoSmithKline plc Recent Development
Table 84. Merck & Co. Inc. Company Details
Table 85. Merck & Co. Inc. Business Overview
Table 86. Merck & Co. Inc. Beta-lactam and Beta-lactamase Inhibitors Product
Table 87. Merck & Co. Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
Table 88. Merck & Co. Inc. Recent Development
Table 89. Mylan N.V. Company Details
Table 90. Mylan N.V. Business Overview
Table 91. Mylan N.V. Beta-lactam and Beta-lactamase Inhibitors Product
Table 92. Mylan N.V. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
Table 93. Mylan N.V. Recent Development
Table 94. Novartis International AG (Sandoz) Company Details
Table 95. Novartis International AG (Sandoz) Business Overview
Table 96. Novartis International AG (Sandoz) Beta-lactam and Beta-lactamase Inhibitors Product
Table 97. Novartis International AG (Sandoz) Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
Table 98. Novartis International AG (Sandoz) Recent Development
Table 99. Pfizer Inc. Company Details
Table 100. Pfizer Inc. Business Overview
Table 101. Pfizer Inc. Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
Table 102. Pfizer Inc. Recent Development
Table 103. Sanofi Company Details
Table 104. Sanofi Business Overview
Table 105. Sanofi Beta-lactam and Beta-lactamase Inhibitors Product
Table 106. Sanofi Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
Table 107. Sanofi Recent Development
Table 108. Teva Pharmaceutical Industries Ltd Company Details
Table 109. Teva Pharmaceutical Industries Ltd Business Overview
Table 110. Teva Pharmaceutical Industries Ltd Beta-lactam and Beta-lactamase Inhibitors Product
Table 111. Teva Pharmaceutical Industries Ltd Revenue in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021) & (US$ Million)
Table 112. Teva Pharmaceutical Industries Ltd Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Penicillin Features
Figure 3. Cephalosporin Features
Figure 4. Carbapenem Features
Figure 5. Monobactam Features
Figure 6. Combination Features
Figure 7. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Application: 2020 VS 2027
Figure 8. Oral Case Studies
Figure 9. Intravenous Case Studies
Figure 10. Others Case Studies
Figure 11. Beta-lactam and Beta-lactamase Inhibitors Report Years Considered
Figure 12. Global Beta-lactam and Beta-lactamase Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Beta-lactam and Beta-lactamase Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions: 2020 VS 2027
Figure 15. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Regions (2022-2027)
Figure 16. Global Beta-lactam and Beta-lactamase Inhibitors Market Share by Players in 2020
Figure 17. Global Top Beta-lactam and Beta-lactamase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Beta-lactam and Beta-lactamase Inhibitors as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Beta-lactam and Beta-lactamase Inhibitors Revenue in 2020
Figure 19. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2016-2021)
Figure 20. Global Beta-lactam and Beta-lactamase Inhibitors Revenue Market Share by Type (2022-2027)
Figure 21. North America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2016-2027)
Figure 23. North America Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2016-2027)
Figure 24. North America Beta-lactam and Beta-lactamase Inhibitors Market Share by Country (2016-2027)
Figure 25. United States Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2016-2027)
Figure 29. Europe Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2016-2027)
Figure 30. Europe Beta-lactam and Beta-lactamase Inhibitors Market Share by Country (2016-2027)
Figure 31. Germany Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Beta-lactam and Beta-lactamase Inhibitors Market Share by Region (2016-2027)
Figure 41. China Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2016-2027)
Figure 49. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2016-2027)
Figure 50. Latin America Beta-lactam and Beta-lactamase Inhibitors Market Share by Country (2016-2027)
Figure 51. Mexico Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Beta-lactam and Beta-lactamase Inhibitors Market Share by Country (2016-2027)
Figure 57. Turkey Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Beta-lactam and Beta-lactamase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Laboratories Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
Figure 61. Allergan Plc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
Figure 63. GlaxoSmithKline plc Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
Figure 64. Merck & Co. Inc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
Figure 65. Mylan N.V. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
Figure 66. Novartis International AG (Sandoz) Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
Figure 67. Pfizer Inc. Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
Figure 69. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Beta-lactam and Beta-lactamase Inhibitors Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---